Not applicableStudy completedNCT07498413What this trial is testingEpidemiology and Treatment of HR+/HER2- Breast Cancer in EnglandWho this might be right forBreast Cancer Novartis Pharmaceuticals 218,677
Large-scale testing (Phase 3)Looking for participantsNCT07190443What this trial is testingAdjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)Who this might be right forBreast CancerLocoregional RecurrenceAbemaciclib+1 more Japanese Foundation for Cancer Research 290
Large-scale testing (Phase 3)Study completedNCT02422615What this trial is testingStudy of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.Who this might be right forAdvanced Breast Cancer Novartis Pharmaceuticals 726
Post-approval studies (Phase 4)Looking for participantsNCT05452213What this trial is testingComprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer PatientsWho this might be right forBreast CancerBreast NeoplasmsBreast Neoplasm Female+4 more Institut fuer Frauengesundheit 1,000
Testing effectiveness (Phase 2)UnknownNCT00687648What this trial is testingCyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast CancerWho this might be right forBreast Cancer National Cancer Centre, Singapore 70
Large-scale testing (Phase 3)Temporarily pausedNCT05503108What this trial is testingFasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast CancerWho this might be right forFasting Mimicking DietHER2-negative Breast CancerHormone Receptor-positive Breast Cancer+3 more Leiden University Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT07380646What this trial is testingThe Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast CancerWho this might be right forLeucogenRibociclibNeutropenia (Low White Blood Cell Count)+1 more Second Affiliated Hospital, Zhejiang University, School of Medicine 94
Large-scale testing (Phase 3)Active Not RecruitingNCT04305496What this trial is testingCapivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast CancerWho this might be right forLocally Advanced (Inoperable) or Metastatic Breast Cancer AstraZeneca 818
Not applicableStudy completedNCT04736576What this trial is testingStudy to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine MonotherapyWho this might be right forBreast Cancer Pfizer 99
Not applicableEnded earlyNCT05488145What this trial is testingA Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine TherapyWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8HER2-Negative Breast Carcinoma+1 more Emory University 21
Testing effectiveness (Phase 2)Ended earlyNCT03430466What this trial is testingAnti PD-L1 Antibody + Anti CTLA-4 Antibody in Combination With Hormone Therapy in Patients With Hormone Receptor Positive HER2-negative Recurrent or Metastatic Breast CancerWho this might be right forBreast Cancer Kyoto Breast Cancer Research Network 1
Testing effectiveness (Phase 2)Study completedNCT03671330What this trial is testingEfficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.Who this might be right forBreast Cancer Novartis Pharmaceuticals 327
Testing effectiveness (Phase 2)Looking for participantsNCT07558733What this trial is testingSapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast CancerWho this might be right forHR+ HER2- Breast Cancer Faeth Therapeutics 32
Not applicableLooking for participantsNCT07073755What this trial is testingReal-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXdWho this might be right forMetastatic Breast CancerDrug ResistanceHormone Receptor-Positive Breast Cancer+3 more Hunan Cancer Hospital 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02942355What this trial is testingTrial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast CancerWho this might be right forFemale Breast CarcinomaBreast Cancer Wake Forest University Health Sciences 40
Testing effectiveness (Phase 2)Looking for participantsNCT06517212What this trial is testingTirzepatide Weight Loss for MRD+ Early Breast CancerWho this might be right forBreast CancerBreast NeoplasmsBreast Cancers Baylor Research Institute 48
Testing effectiveness (Phase 2)Study completedNCT02404844What this trial is testingTrial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast CancerWho this might be right forBreast Cancer University Hospital, Essen 48
Not applicableLooking for participantsNCT07743944What this trial is testingA Real-world Study Observing Treatment Patterns and Clinical Results for Patients in China With Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer.Who this might be right forBreast Cancer AstraZeneca 2,000
Testing effectiveness (Phase 2)Ended earlyNCT02273752What this trial is testingPharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerWho this might be right forEstrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more Emory University 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07619066What this trial is testingA Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations.Who this might be right forAdvanced Breast CancerHormone Receptor Positive / HER2-negative Breast CancerHER2 Mutation MedSIR 25